≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm, without specification of site

DOID Endpoint Browser

C3_SECONDARY_WITHOUT_SITESPEC

cancer: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C80
  • Cause of death: ICD-9 — 199
  • Cause of death: ICD-8 — 199
  • Cancer registry: Topography ICD-O-3 — C80
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

1178

4. Check minimum number of events

None

1178

5. Include endpoints

None

1178

6. Filter based on genotype QC (FinnGen only)

1178

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm, without specification of site based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1178 440 738
Unadjusted period prevalence (%) 0.26 0.15 0.33
Median age at first event (years) 71.84 70.75 72.48

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1122
Matched controls
11218
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
314.9
287
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
595.0
247.8
237
5
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
205.7
191
*
130
Kela drug reimbursment
Malignant tumour
8.7
148.8
362
582
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
22.5
124.0
184
97
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
122.2
115
*
8070/3-C80.9
ICD-O-3
Squamous cell carcinoma, NOS, of unknown primary site
+∞
114.6
108
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
73.7
94.4
107
16
8010/3-C80.9
ICD-O-3
Carcinoma, NOS, of unknown primary site
+∞
88.7
84
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
86.0
409
1347
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
153.1
81.2
85
6
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
50.6
77.3
93
20
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
107.6
73.9
80
8
N02AA05
ATC
oxycodone; systemic
3.9
72.4
369
1257
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
71.6
68
*
Z51.5
ICD-10 Finland
Palliative care
5.6
64.6
208
441
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
8.8
58.5
131
166
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.0
57.0
126
156
JN4BD
NOMESCO Finland
Extensive body CT
4.1
57.0
253
742
H02AB02
ATC
dexamethasone; systemic
4.6
56.6
220
567
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
76.2
51.5
58
8
C80.9
ICD-10 Finland
Malignant neoplasm, primary site unspecified
509.5
49.8
49
*
A04AA02
ATC
granisetron; systemic, transdermal
6.0
46.6
137
255
8246/3-C80.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of unknown primary site
+∞
44.0
42
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
11.6
43.2
82
76
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
14.2
41.2
71
53
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.9
40.9
107
170
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
12.2
37.0
68
59
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.1
35.5
117
248
8720/3-C80.9
ICD-O-3
Malignant melanoma, NOS, of unknown primary site
+∞
34.6
33
*
A04AA01
ATC
ondansetron; systemic, rectal
4.5
32.9
123
297
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
21.7
31.5
46
22
L03AA13
ATC
pegfilgrastim; parenteral
6.3
29.2
80
135
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
67.9
29.0
33
5
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
18.3
28.5
44
25
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
9.5
28.4
59
65
EMB10
NOMESCO Finland
Tonsillectomy
7.6
27.6
66
92
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
+∞
27.2
26
*
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
77.1
26.9
30
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
13.2
26.8
47
37
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
23.1
26.7
38
17
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.7
26.5
122
356
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.0
25.8
73
129
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
7.2
24.8
61
89
8480/3-C80.9
ICD-O-3
Mucinous adenocarcinoma of unknown primary site
+∞
24.0
23
*
JN4AD
NOMESCO Finland
Body CT examination
3.2
24.0
137
471
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.0
23.9
79
168
R18
ICD-10 Finland
Ascites
7.9
23.0
53
70
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
6.2
22.3
61
103
8240/3-C80.9
ICD-O-3
Neuroendocrine tumor, NOS, of unknown primary site
+∞
21.9
21
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
21.9
341
1988
A98
ICPC
Health maint/preventive medicine
0.5
21.4
605
7686
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
28.7
21.0
28
10
JN4CD
NOMESCO Finland
Very extensive body CT
4.0
20.3
83
218
8041/3-C80.9
ICD-O-3
Small cell carcinoma, NOS, of unknown primary site
+∞
19.8
19
*
8249/3-C80.9
ICD-O-3
Neuroendocrine tumor, grade 2 of unknown primary site
+∞
19.8
19
*
H01CB02
ATC
octreotide; parenteral
25.1
19.6
27
11
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.9
19.5
37
35
L03AA02
ATC
filgrastim; parenteral
5.6
19.1
56
104
WW500
NOMESCO Finland
Blood transfusion
4.0
19.1
78
205
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
10.9
19.0
36
34
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
35.0
18.9
24
7
WF003
NOMESCO Finland
Adjuvant radiotherapy
4.5
18.9
68
158
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.3
18.3
97
316
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
53.4
18.0
21
*
UJC01
NOMESCO Finland
Scopy of lower throat
9.1
17.7
37
42
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.4
16.6
36
44
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
20.4
16.5
24
12
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.3
16.4
39
55
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
12.4
16.4
29
24
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
16.4
173
840
JDB10
NOMESCO Finland
Percutaneous gastrostomy
7.0
16.3
40
59
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.3
16.3
83
263
WF002
NOMESCO Finland
Radical radiotherapy
3.3
16.2
83
264
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
24.9
16.0
22
9
PJA10
NOMESCO Finland
Exploration of lymph nodes
9.2
16.0
33
37
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
15.8
350
2264
8020/3-C80.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of unknown primary site
+∞
15.7
15
*
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
15.7
15
*
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
15.0
76
240
XX3DW
NOMESCO Finland
Time consuming IT work
2.5
14.9
125
541
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
14.4
14.6
24
17
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
11.0
14.5
27
25
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
36.5
14.5
18
5
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
6.0
14.3
39
67
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
43.1
14.1
17
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.8
14.1
35
53
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
17.8
13.9
21
12
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
54.0
13.8
16
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
24.1
13.8
19
8
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
20.3
13.8
20
10
WZC30
NOMESCO Finland
Teaching
2.2
13.7
142
683
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.4
13.6
40
76
UDQ22
NOMESCO Finland
Microlaryngoscopy
8.9
13.5
28
32
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
16.4
13.5
21
13
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.1
12.9
31
45
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
5.4
12.8
38
73
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
15.6
12.6
20
13
9670/3-C80.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of unknown primary site
+∞
12.5
12
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
12.3
130
628
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
6.7
12.1
30
46
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
18.3
12.1
18
10
ZX120
NOMESCO Finland
Intravenous
2.2
11.8
120
571
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
9.8
11.8
23
24
J01MA12
ATC
levofloxacin; systemic
1.8
11.6
236
1466
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
11.6
171
950
D77
ICPC
Malignant digestive neopl other/NOS
13.8
11.5
19
14
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.9
11.4
68
242
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
35.4
11.3
14
*
E34.0
ICD-10 Finland
Carcinoid syndrome
17.2
11.2
17
10
B01AB10
ATC
tinzaparin; parenteral
2.6
11.2
84
343
R4190
NOMESCO Finland
Nutritional therapy
4.4
10.9
39
92
WF004
NOMESCO Finland
Palliative radiotherapy
4.1
10.7
41
104
L01AX03
ATC
temozolomide; systemic
13.0
10.7
18
14
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
60.6
10.6
12
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
6.3
10.5
27
44
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
+∞
10.4
10
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.8
10.3
33
70
H01CB03
ATC
lanreotide; parenteral
19.0
10.3
15
8
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
23.6
10.3
14
6
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
10.2
252
1653
1XC02
NOMESCO Finland
NA
8.0
10.1
22
28
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.5
10.1
21
25
C83.1
ICD-10 Finland
Mantle cell lymphoma
14.7
10.0
16
11
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.0
9.9
56
192
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
9.6
63
1278
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.1
9.4
35
87
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.8
9.4
30
64
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
9.6
9.3
18
19
A79
ICPC
Malignancy NOS
4.7
8.9
29
63
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
10.8
8.8
16
15
JAH00
NOMESCO Finland
Laparotomy
3.2
8.8
45
146
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.2
8.7
43
136
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
16.4
8.6
13
8
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
90.7
8.4
9
*
C76.7
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Other ill-defined sites
90.7
8.4
9
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
8.4
128
2031
9590/3-C80.9
ICD-O-3
Malignant lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
J94.8
ICD-10 Finland
Other specified pleural conditions
3.5
8.2
37
109
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.3
8.2
74
333
A04AD12
ATC
aprepitant; systemic
4.9
8.1
25
52
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
9.0
8.0
16
18
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
22.2
8.0
11
5
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
22.2
8.0
11
5
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
22.2
8.0
11
5
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
7.8
7.9
17
22
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
5.2
7.9
23
45
UJC02
NOMESCO Finland
Rigid oesophagoscopy
6.2
7.9
20
33
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
5.8
7.8
21
37
JAH01
NOMESCO Finland
Laparoscopy
3.1
7.8
41
136
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
9.5
7.8
15
16
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.4
7.7
26
60
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
7.7
57
1110
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
7.6
105
571
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
10.1
7.5
14
14
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
7.5
135
801
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
4.9
7.5
23
48
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
80.6
7.4
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
7.3
97
515
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
7.3
64
286
A07AA02
ATC
nystatin; oral
2.1
7.3
76
367
JAL30
NOMESCO Finland
Omentectomy
6.9
7.3
17
25
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
7.3
7
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
6.3
7.3
18
29
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.7
7.2
23
50
H29
ICPC
Ear symptom/complaint other
0.4
7.1
22
592
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
7.1
170
2448
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.0
7.1
38
129
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
6.1
7.1
18
30
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
8.8
7.1
14
16
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
7.0
343
4332
C10AA05
ATC
atorvastatin; oral
0.7
7.0
248
3311
C10AA07
ATC
rosuvastatin; oral
0.6
6.9
103
1656
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
5.9
6.9
18
31
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
4.7
6.9
22
48
L01BC06
ATC
capecitabine; oral
2.7
6.8
44
166
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.6
6.8
29
83
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.8
437
3497
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.7
6.8
28
78
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
40.3
6.8
8
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
16.8
6.7
10
6
JN6AD
NOMESCO Finland
CT of torso and neck
4.9
6.7
20
41
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
22.7
6.7
9
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
22.7
6.7
9
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
5.2
6.6
19
37
C83.00
ICD-10 Finland
Lymphocytic lymphoma
7.9
6.6
14
18
K85
ICPC
Elevated blood pressure
0.5
6.6
52
995
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.5
150
958
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
70.2
6.4
7
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
70.2
6.4
7
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
14.4
6.4
10
7
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
11.1
6.3
11
10
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
18.1
6.3
9
5
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
26.8
6.2
8
*
M04AA01
ATC
allopurinol; systemic
1.6
6.2
188
1285
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
6.2
200
2728
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.8
6.1
36
130
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
7.7
6.1
13
17
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.3
6.1
52
229
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
8.6
6.1
12
14
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
0.5
6.0
58
1047
ZX112
NOMESCO Finland
Subcutaneous
3.3
6.0
28
87
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
5.6
6.0
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
248
685
4.32
81.70
1.5
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
303
983
3.80
79.50
2.8
3.9
ug/l
51.6
23.8
1.04
257
827
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
145
357
4.49
54.51
2.2
3.2
u/ml
2418.1
8608.5
0.39
114
301
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
90
199
4.81
38.39
2.4
3.3
u/ml
1517.7
1832.3
0.08
81
189
(40768441) Liver Pathology biopsy report
44
52
8.75
34.53
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
500
7159
0.48
33.34
6.0
6.4
mmol/mol
41.8
41.2
0.72
422
6450
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
83
197
4.46
32.39
1.2
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
42
53
8.18
31.26
1.1
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
102
290
3.76
31.15
4.8
3.1
u/ml
245.0
62.7
2.05
102
278
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
240
1112
2.45
30.66
5.8
3.4
u/l
317.1
242.5
1.93
226
1039
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
542
7453
0.49
30.32
4.1
5.2
mmol/l
2.6
2.5
0.21
454
6629
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
520
7220
0.50
29.43
3.8
4.6
mmol/l
4.5
4.4
0.37
453
6477
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
518
7140
0.51
27.63
3.8
4.5
mmol/l
1.4
1.4
0.78
445
6334
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
554
7409
0.52
25.69
4.8
4.9
mmol/l
6.2
6.1
0.33
479
6510
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
513
6900
0.55
22.41
3.6
4.1
mmol/l
1.3
1.3
0.79
433
6067
(40768795) Lymph node Pathology biopsy report
39
69
5.81
21.27
1.1
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
683
8351
0.57
19.30
38.6
25.8
g/l
123.5
131.6
29.72
667
8137
(3026361) Erythrocytes [#/volume] in Blood
683
8349
0.57
19.24
38.3
25.6
e12/l
4.1
4.4
20.66
655
8027
(3007461) Platelets [#/volume] in Blood
683
8348
0.57
19.21
38.3
25.7
e9/l
253.3
237.9
4.13
660
8062
(3024731) MCV [Entitic volume]
683
8348
0.57
19.21
38.2
25.6
fl
91.5
91.8
0.96
665
8136
(3035941) MCH [Entitic mass]
683
8348
0.57
19.21
38.2
25.5
pg
30.2
30.4
1.80
665
8134
(3010813) Leukocytes [#/volume] in Blood
684
8353
0.57
19.11
38.3
25.7
e9/l
7.5
7.0
3.21
657
8028
(3012095) Magnesium [Moles/volume] in Serum or Plasma
241
1385
1.93
16.91
4.6
2.9
mmol/l
0.8
0.8
4.81
219
1275
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
79
1893
0.38
16.68
1.7
1.6
mmol/l
1.6
1.3
1.93
67
1553
(40761511) CBC panel - Blood by Automated count
642
7875
0.59
16.66
23.7
17.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
673
8154
0.59
16.56
29.5
21.4
mmol/l
4.0
4.0
1.24
655
7871
(3019550) Sodium [Moles/volume] in Serum or Plasma
673
8144
0.59
16.32
29.5
21.2
mmol/l
138.4
139.5
15.84
655
7870
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
560
7079
0.60
16.06
26.2
16.9
ml/min/173m2
75.4
71.2
4.59
493
5889
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
667
8033
0.61
15.01
17.2
10.6
u/l
28.8
24.6
3.27
640
7636
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
584
4472
1.61
14.07
11.6
5.7
umol/l
17.5
12.2
2.37
564
4205
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
31
65
4.87
14.07
1.6
3.5
u/ml
42.4
68.3
0.47
31
65
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
552
6898
0.62
13.91
5.1
4.6
mu/l
7.4
2.2
0.50
486
6092
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
151
817
1.97
12.43
2.1
2.0
g/l
0.2
0.2
1.63
134
754
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
244
3621
0.59
12.02
2.6
2.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
54
192
2.90
11.51
2.3
2.3
umol/l
38.5
34.0
0.50
38
146
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
66
266
2.57
11.07
1.7
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
24
51
4.78
10.74
3.1
2.0
e9/l
1.0
0.9
0.18
13
30
(3044889) 12 lead EKG panel
443
5628
0.66
10.50
4.6
4.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
250
3589
0.61
10.36
4.2
5.4
ug/l
4.0
5.2
0.30
214
3146
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
18
31
5.88
10.08
1.2
1.7
e6/l
24376.7
50163.2
0.22
12
22
(42870588) Differential panel, method unspecified - Blood
363
2655
1.53
9.73
7.5
5.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
16
26
6.22
9.47
1.4
2.0
—
—
—
0
0
(4281824)
28
75
3.80
9.36
1.2
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
191
2865
0.60
9.29
3.9
4.7
%
21.5
22.1
0.23
101
1475
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
56
230
2.51
9.07
1.6
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
156
942
1.76
9.00
4.2
2.5
umol/l
16.0
9.4
0.81
138
817
(3003338) MCHC [Mass/volume]
500
6104
0.69
8.99
34.4
23.4
g/l
330.2
331.1
1.15
491
6018
(3044007) Cell count panel - Peritoneal fluid
16
28
5.78
8.81
1.3
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
672
7748
0.69
8.58
28.2
17.8
mg/l
38.4
28.2
8.74
621
6415
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
74
354
2.16
8.48
2.6
2.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
151
2347
0.59
8.32
1.6
1.6
nmol/l
19.6
20.2
0.17
135
1972
(3009542) Hematocrit [Volume Fraction] of Blood
560
6646
0.70
8.22
27.2
19.1
%
36.3
38.2
3.51
345
4063
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
35
4.91
7.90
2.0
2.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
38
138
2.81
7.86
1.4
1.3
e6/l
63512.2
83481.8
0.16
27
81
(3012441) Differential panel - Pleural fluid
38
139
2.79
7.76
1.4
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
22
58
3.85
7.54
1.9
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
443
3507
1.42
7.51
7.6
5.2
%
0.6
0.6
0.58
407
3240
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
37
4.65
7.42
1.8
1.9
%
12.7
18.7
—
6
15
(3023368) Bacteria identified in Blood by Culture
374
2880
1.44
7.36
5.3
4.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
175
2556
0.63
7.30
2.8
3.1
mmol/l
7.3
7.1
0.19
131
2059
(3020682) Albumin/Creatinine [Ratio] in Urine
186
2676
0.64
7.24
3.5
3.9
mg/mmol
6.7
9.4
0.68
117
1710
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
293
3846
0.68
7.24
1.9
2.1
pmol/l
92.0
91.5
0.05
153
1981
(3042936) Bacteria identified in Isolate by Culture
192
1297
1.57
7.13
2.1
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
450
3609
1.40
6.95
7.7
5.2
%
2.5
2.8
2.59
416
3328
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
35
4.62
6.94
2.4
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
35
4.62
6.94
2.4
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
136
849
1.68
6.93
3.0
2.5
g/l
64.7
66.0
0.84
119
748
(3019069) Monocytes/100 leukocytes in Blood
451
3621
1.40
6.91
8.1
5.5
%
9.2
9.0
0.43
418
3355
(3002385) Erythrocyte distribution width [Ratio]
516
6109
0.72
6.80
31.8
21.2
%
14.6
14.0
11.45
506
5941
(3002030) Lymphocytes/100 leukocytes in Blood
458
3694
1.39
6.80
7.9
5.5
%
23.2
25.4
3.03
424
3397
(3023199) Leukocytes [#/volume] in Pleural fluid
39
156
2.55
6.73
1.4
1.4
e6/l
1478.5
1386.3
0.07
32
109
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
36
4.49
6.72
2.6
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
268
1970
1.47
6.65
13.4
6.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
68
348
2.01
6.57
1.3
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
37
147
2.57
6.48
2.5
2.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
478
3910
1.37
6.41
7.0
4.6
g/l
32.0
34.3
11.19
446
3592
(3012516) Albumin [Mass/volume] in Urine
178
2519
0.65
6.28
3.2
3.2
mg/l
1768.8
349.0
1.34
115
1626
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
134
2017
0.62
6.27
2.6
3.3
ug/l
0.6
0.8
3.67
99
1423
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
342
2654
1.41
6.27
3.5
2.4
u/l
52.6
56.7
1.05
319
2435
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
15
35
4.33
6.03
1.5
1.3
ug/l
82.2
26.8
—
9
16
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
100
2.84
6.02
1.4
1.2
u/l
20.2
9.7
1.84
22
77
(40768806) Pleura Pathology biopsy report
36
147
2.49
5.99
1.7
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
84
3.02
5.98
1.2
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
276
2078
1.43
5.96
6.4
3.9
%
80.9
83.1
0.74
271
2025
(3019198) Lymphocytes [#/volume] in Blood
473
3896
1.36
5.95
7.3
5.1
e9/l
1.6
1.8
1.49
425
3393
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
473
5608
0.74
5.92
4.2
3.7
pmol/l
15.1
15.1
0.12
410
4916
(3017143) Hepatitis C virus Ab [Presence] in Serum
96
575
1.73
5.71
1.4
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
143
2078
0.65
5.66
2.8
3.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
82
472
1.79
5.59
2.1
1.8
ug/l
1.7
2.2
0.22
72
395
(3006315) Basophils [#/volume] in Blood
462
3824
1.34
5.52
7.1
5.0
e9/l
0.0
0.0
0.21
408
3268
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
17
47
3.66
5.49
4.6
3.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
115
732
1.63
5.45
3.3
2.4
u/l
31.8
31.3
0.06
99
618
(3001604) Monocytes [#/volume] in Blood
459
3806
1.34
5.38
7.2
5.0
e9/l
0.7
0.6
0.99
405
3240
(3026692) Albumin [Mass/volume] in Peritoneal fluid
13
30
4.37
5.30
1.0
1.1
g/l
16.8
15.0
0.33
13
19
(3013650) Neutrophils [#/volume] in Blood by Automated count
531
4505
1.33
5.28
15.7
8.0
e9/l
4.5
4.4
0.48
480
3911
(3018010) Neutrophils/100 leukocytes in Blood
438
3622
1.33
5.18
7.6
5.2
%
60.8
59.1
1.90
406
3353
(3013115) Eosinophils [#/volume] in Blood
472
3955
1.32
5.06
7.6
5.2
e9/l
0.2
0.2
3.35
422
3431
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
368
1.84
5.01
1.9
2.4
u/ml
0.3
0.4
0.83
37
209
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
252
3221
0.72
4.89
2.2
2.2
nmol/l
75.1
78.6
1.16
222
2766
(3028026) IgM [Mass/volume] in Serum or Plasma
73
425
1.77
4.82
2.8
1.7
g/l
1.7
1.7
0.05
65
384
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
38
178
2.17
4.70
1.7
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
30
127
2.40
4.68
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
340
2749
1.33
4.59
3.2
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
96
612
1.62
4.55
1.3
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
21
4.79
4.53
1.8
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
35
161
2.21
4.53
2.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
49
3.30
4.48
2.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
49
3.30
4.48
2.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
49
3.30
4.48
2.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
49
3.30
4.48
2.4
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
44
223
2.01
4.45
1.9
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
232
1.98
4.35
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
232
1.98
4.35
1.4
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
9
8.94
4.28
1.0
2.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
298
2385
1.33
4.27
4.8
3.0
u/l
80.5
34.9
0.99
282
2266
(3042111) Morphology [Interpretation] in Bone marrow Narrative
34
159
2.17
4.24
1.4
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
509
5818
0.78
4.23
4.7
4.0
mm/h
23.4
15.1
10.09
447
5243
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
61
1006
0.58
4.10
1.2
1.2
u/ml
39.4
13.5
0.69
22
355
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
41
210
1.99
4.05
1.9
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
365
3029
1.30
4.00
6.6
3.3
mmol/l
2.4
2.3
0.25
332
2575
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
155
2082
0.71
3.96
1.5
1.8
pmol/l
449.9
12263467.8
1.32
111
1688
(3004809) Band form neutrophils/100 leukocytes in Blood
32
151
2.15
3.93
4.7
3.5
%
2.7
1.7
0.50
25
119
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
29
3.82
3.81
1.5
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
43
230
1.90
3.77
1.3
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
122
2.24
3.69
1.5
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
82
532
1.58
3.66
3.6
2.6
g/l
10.3
10.9
0.45
76
476
(40765096) Chromosome analysis panel by Banding
11
30
3.69
3.64
1.1
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
40
3.28
3.63
4.2
2.3
e6/l
496.8
674.9
—
8
17
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
104
2.33
3.61
1.5
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
51
2.97
3.58
2.3
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
86
2.47
3.56
2.2
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
73
1111
0.63
3.53
11.7
9.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
17
5.33
3.51
5.1
2.0
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
9
17
5.33
3.51
1.0
1.3
g/l
30.7
32.0
—
9
12
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
81
2.49
3.47
2.3
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
256
2064
1.31
3.42
2.7
2.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
26
120
2.19
3.40
1.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
154
2.04
3.37
1.5
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
18
5.03
3.37
1.9
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
333
3928
0.79
3.34
4.0
4.1
estimate
0.0
0.0
0.00
76
749
(3001122) Ferritin [Mass/volume] in Serum or Plasma
272
3279
0.78
3.25
2.7
2.7
ug/l
304.5
152.9
3.45
240
2934
(40760888) Immunoglobulin light chains.free panel - Serum
44
250
1.79
3.24
2.9
3.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
340
3981
0.79
3.16
4.1
4.2
estimate
0.0
0.0
0.00
74
737
(3035880) pH of Pleural fluid
18
73
2.49
3.13
1.1
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
454
3963
1.24
3.09
8.6
11.5
inr
1.3
1.4
2.01
111
1089
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
74
2.45
3.05
1.4
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
336
3921
0.80
2.99
5.4
5.6
estimate
0.0
0.0
0.00
75
739
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
51
2.77
2.99
2.1
2.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
21
94
2.26
2.97
1.3
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
211
0.33
2.93
1.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
46
2.85
2.92
1.5
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
58
2.61
2.88
1.4
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
29
150
1.96
2.86
3.6
3.7
%
61.5
59.9
0.20
29
150
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
47
2.79
2.82
4.2
2.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
47
2.79
2.82
1.5
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
45
269
1.70
2.82
3.2
3.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
147
1887
0.75
2.78
3.9
4.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
23
3.93
2.77
1.0
3.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
512
5685
0.82
2.73
4.8
4.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
189
1507
1.30
2.73
4.3
4.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
49
2.67
2.63
1.2
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
32
178
1.82
2.57
2.3
2.2
%
224.8
201.8
0.74
32
170
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
121
2.00
2.57
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
328
0.45
2.55
1.9
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
27
143
1.91
2.52
3.0
3.1
e9/l
4.9
4.5
0.31
27
143
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
21
3.83
2.46
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
21
3.83
2.46
1.0
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
23
428
0.53
2.45
3.7
4.5
%
0.9
0.9
0.16
23
401
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
125
1.94
2.36
1.5
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
174
2135
0.78
2.33
1.9
1.8
nmol/l
1216.2
1201.4
0.07
118
1580
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
23
3.49
2.27
1.1
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
99
2.04
2.27
1.1
1.2
u/ml
299.5
313.0
0.07
15
54
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
95
706
1.38
2.23
1.6
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
114
1.95
2.21
1.1
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
24
426
0.55
2.21
3.5
4.5
%
1.6
1.5
0.11
24
398
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
14
4.30
2.15
1.5
3.0
%
166.0
127.0
—
6
14
(40768804) Tissue Pathology biopsy report
346
3030
1.20
2.14
2.8
2.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
123
1.89
2.12
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
152
1219
1.28
2.12
4.8
4.9
mmol/l
1.0
1.0
0.08
135
1110
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
88
2.06
2.12
1.2
1.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
111
853
1.33
2.11
7.4
6.2
mmol/l
10.8
11.8
0.55
104
802
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
109
1.94
2.11
5.7
4.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
25
3.21
2.09
1.0
1.1
—
—
—
0
0
(3013512) EKG study
228
2681
0.81
2.07
4.5
4.4
—
—
—
0
0
(4015189)
9
31
2.92
2.07
2.0
2.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
277
3192
0.83
2.05
3.5
3.2
ng/l
2469.0
2188.8
0.38
238
2759
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
15
4.02
2.04
2.5
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
308
2681
1.20
2.02
4.9
3.8
ph
7.4
7.4
1.00
69
514
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
20
104
1.94
2.01
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
18
90
2.02
2.01
1.2
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
38
240
1.60
2.00
2.8
4.8
mmol/l
3.9
2.6
1.16
25
162
(3034860) Kappa light chains.free [Mass/volume] in Serum
50
337
1.51
1.99
2.8
3.3
mg/l
77.6
76.5
0.01
38
270
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
43
641
0.66
1.97
1.4
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
50
338
1.50
1.97
2.8
3.3
mg/l
32.1
84.1
0.79
38
275
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
84
2.04
1.96
2.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
84
2.04
1.96
2.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
84
2.04
1.96
2.4
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
135
1.79
1.92
1.5
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
53
0.00
1.87
0.0
2.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
49
334
1.49
1.87
1.3
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
43
286
1.52
1.84
1.3
1.8
u/l
34.1
37.4
0.50
35
242
(46235355) HIV 1 and 2 tests - Meaningful Use set
94
721
1.33
1.84
1.5
1.6
—
—
—
0
0
(4133840)
5
12
4.18
1.82
3.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
47
2.35
1.78
2.9
3.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
451
4094
1.16
1.77
6.5
5.6
mmol/l
1.2
1.2
0.60
416
3654
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
67
2.10
1.76
1.1
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
209
1.60
1.75
1.4
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
92
710
1.32
1.74
2.7
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
140
1.73
1.72
1.1
1.2
—
—
—
0
0
(4010399)
37
551
0.66
1.72
1.6
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
43
621
0.68
1.71
3.0
3.0
g/l
119.2
125.3
1.25
43
607
(3007566) Smooth muscle Ab [Titer] in Serum
26
156
1.68
1.70
1.1
1.1
titre
82.0
63.0
—
5
10
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
78
1018
0.75
1.69
4.2
4.7
%
35.7
32.8
1.04
50
647
(3048689) Calprotectin [Mass/mass] in Stool
50
695
0.71
1.62
1.6
2.1
ug/g
141.2
162.6
0.21
38
535
(1002224) Polysomnography panel
9
189
0.47
1.62
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
77
1.96
1.59
1.7
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
109
1349
0.79
1.59
1.2
1.2
u/ml
1.5
1.4
0.07
24
327
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
391
1.40
1.54
3.0
2.4
g/l
3.5
3.8
0.63
33
269
(3027945) Reticulocytes/100 erythrocytes in Blood
146
1214
1.23
1.53
3.1
2.2
%
1.9
1.8
0.67
123
1063
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
392
1.40
1.52
3.0
2.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
273
3075
0.85
1.51
4.4
4.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
356
0.61
1.51
1.5
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
393
1.39
1.51
3.0
2.4
g/l
8.0
7.5
0.77
33
280
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
51
2.17
1.51
1.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
21
2.87
1.50
1.5
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
212
1833
1.19
1.50
6.3
3.2
mmol/l
2.5
2.5
3.75
187
1590
(40768797) Stomach Pathology biopsy report
124
1019
1.24
1.46
1.2
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
16
3.13
1.44
1.4
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
267
3001
0.86
1.43
3.5
3.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
141
1.64
1.42
1.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
54
398
1.37
1.41
1.2
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
236
2676
0.85
1.41
2.6
2.1
u/l
232.3
249.1
0.10
221
2482
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
365
1.39
1.39
2.2
2.5
g/l
10.3
10.7
0.15
38
300
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
85
1061
0.79
1.35
1.2
1.2
iu/ml
45.8
39.9
0.10
29
341
(3024928) Oxygen saturation in Venous blood
11
209
0.52
1.35
1.8
2.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
24
2.51
1.30
1.5
1.2
—
—
—
0
0
(4094501)
9
176
0.51
1.29
1.0
1.1
—
—
—
0
0
(4034850)
16
268
0.59
1.29
16.7
12.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
412
0.67
1.28
1.1
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
8
35
2.29
1.27
2.0
1.4
u/l
47.8
35.6
—
8
28
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
363
1.37
1.26
3.1
2.5
g/l
3.5
3.2
0.49
34
275
(3019150) Specific gravity of Urine by Refractometry
155
1800
0.84
1.24
4.9
4.6
kg/l
1.0
1.0
0.42
30
265
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
63
488
1.31
1.22
1.9
1.7
g/l
1.8
1.6
0.73
47
420
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
19
2.64
1.21
1.0
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
342
3729
0.88
1.16
4.6
4.3
ng/l
45.4
58.3
0.48
280
2887
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
20
2.51
1.15
1.4
1.6
mmol/l
1.2
1.2
—
5
20
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
48
629
0.75
1.14
1.4
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
22
143
1.55
1.12
1.2
1.2
mmol/l
4.0
3.9
0.07
22
134
(3031040) Bacteria [#/volume] in Urine by Automated count
536
5682
0.90
1.11
5.1
5.2
e6/l
2229.3
2649.4
0.07
20
109
(3029937) Albumin [Presence] in Urine by Test strip
197
2222
0.86
1.10
4.4
4.4
estimate
0.0
0.0
0.00
65
703
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
160
1832
0.85
1.09
4.4
4.2
ng/l
195.5
309.1
0.45
129
1591
(36660697) Celiac disease serology panel - Serum
33
455
0.72
1.09
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
89
1.69
1.08
2.9
3.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
25
169
1.49
1.07
1.1
1.2
—
634.0
—
0
5
(3017181) Myelocytes/100 leukocytes in Blood
79
643
1.25
1.06
4.8
3.8
%
0.8
0.9
0.13
37
212
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
105
1.63
1.06
2.1
2.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
36
486
0.73
1.05
3.7
3.8
%
46.2
46.8
0.05
36
480
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
24
162
1.49
1.04
1.2
1.2
mg/l
638.7
515.2
0.29
24
152
(4062490)
11
60
1.84
1.03
1.5
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
7
34
2.07
1.03
1.1
1.2
umol/l
4.8
6.4
—
7
24
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
34
2.07
1.03
6.7
6.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
411
3826
1.11
1.00
5.1
4.3
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
14
225
0.62
1.00
4.8
5.9
mmol/l
106.1
105.2
0.42
14
201
(3039000) Anion gap in Blood
14
225
0.62
1.00
4.8
5.9
mmol/l
10.6
11.2
0.33
14
201
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
36
266
1.36
0.99
2.6
2.6
g/l
0.0
0.0
0.00
28
240
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.1
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
222
0.63
0.95
1.4
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
46
589
0.77
0.95
4.0
3.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
77
1.70
0.95
1.5
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
116
998
1.18
0.92
4.5
3.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
28
2.15
0.91
1.8
2.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
36
271
1.34
0.90
2.6
2.6
g/l
0.0
0.0
0.00
28
241
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
56
1.79
0.88
1.3
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
90
761
1.20
0.87
6.0
3.7
mmol/l
1.2
1.2
0.32
82
656
(3043410) Blood group antigens tested for on Red Blood Cells
6
30
2.01
0.87
2.3
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
31
1.94
0.84
1.2
2.0
u/ml
4763.3
1242.7
—
6
31
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
47
588
0.79
0.83
1.3
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
47
1.71
0.80
1.1
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
474
4490
1.09
0.79
7.6
6.4
mmol/l
1.2
1.2
1.32
376
3723
(1616796) Gas panel - Central venous blood
30
225
1.34
0.78
2.6
4.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
97
0.51
0.78
1.4
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
41
516
0.79
0.77
3.0
4.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
66
787
0.83
0.76
3.9
3.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
279
0.71
0.76
1.3
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
83
1.57
0.75
1.5
1.3
nmol/l
0.6
0.6
0.02
13
76
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
75
1.61
0.75
1.3
1.3
nmol/l
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
265
0.71
0.73
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
60
1.67
0.72
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
60
1.67
0.72
1.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
39
309
1.27
0.71
2.5
2.4
g/l
35.6
36.5
0.32
31
254
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
69
1.60
0.68
1.5
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
92
0.54
0.67
1.4
1.2
nmol/l
354.2
332.7
—
5
73
(3019230) Fractional oxyhemoglobin in Venous blood
10
155
0.64
0.66
1.9
2.0
%
60.5
61.4
—
10
155
(3014051) Protein [Presence] in Urine by Test strip
14
202
0.69
0.66
1.7
2.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
53
633
0.83
0.65
1.9
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
154
0.65
0.64
1.7
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
36
287
1.26
0.64
2.6
2.5
g/l
0.0
0.0
0.95
28
256
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
417
1.21
0.61
2.7
1.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
1.5
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
10
151
0.66
0.60
1.4
1.8
nmol/l
31.3
42.9
—
10
143
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
43
516
0.83
0.57
6.4
8.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
79
899
0.87
0.56
1.7
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
55
1.46
0.56
1.3
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
69
598
1.16
0.56
4.9
3.9
%
0.1
0.1
0.65
34
193
(3041096) Erythrocytes [Presence] in Urine by Automated
195
2105
0.91
0.56
4.0
3.9
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
63
727
0.86
0.54
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
261
0.76
0.54
1.3
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
61
1.48
0.53
1.2
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
16
117
1.37
0.52
9.2
5.6
mg/l
10.8
12.6
1.41
16
108
(3013826) Glucose [Moles/volume] in Serum or Plasma
491
5099
0.94
0.52
6.1
4.7
mmol/l
6.9
6.9
0.02
471
4803
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
40
333
1.21
0.51
2.6
2.6
g/l
2.1
1.4
0.33
30
277
(3014111) Lactate [Moles/volume] in Serum or Plasma
95
849
1.13
0.51
4.8
6.2
mmol/l
1.7
1.4
0.88
88
809
(3023520) Reticulocytes [#/volume] in Blood
98
878
1.13
0.51
2.9
2.3
e9/l
67.4
67.3
0.01
72
694
(3003694) ABO and Rh group [Type] in Blood
198
1842
1.09
0.51
1.4
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
247
0.77
0.50
1.4
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
110
0.63
0.48
1.3
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
297
2815
1.07
0.48
3.4
3.5
e6/l
149.5
106.4
0.37
248
2237
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
143
0.70
0.48
2.3
2.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
235
2497
0.93
0.47
2.0
2.2
mg/l
3.6
3.2
1.32
188
2098
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
244
0.78
0.47
1.6
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
94
1.39
0.46
3.5
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
85
0.59
0.45
1.0
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
115
1052
1.10
0.43
1.3
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
90
995
0.90
0.43
2.1
1.8
—
—
—
0
0
(3020891) Body temperature
34
403
0.84
0.42
5.1
4.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
161
1499
1.09
0.42
2.1
2.4
umol/l
10.6
11.7
1.21
146
1365
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
15
0.00
0.41
0.0
7.3
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
16
0.00
0.41
0.0
2.1
—
2.8
—
0
6
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
17
0.00
0.40
0.0
7.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
22
271
0.81
0.40
1.1
1.1
—
36.2
—
0
5
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
227
0.79
0.40
1.6
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
607
1.13
0.40
1.4
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
101
0.69
0.39
3.4
4.4
umol/l
294.7
339.3
—
7
88
(3016038) Potassium [Moles/volume] in Urine
8
61
1.31
0.39
1.0
1.1
mmol/l
29.0
32.9
—
8
55
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
232
2200
1.07
0.38
3.8
2.7
umol/l
2288.8
8849.7
2.25
196
1822
(36304419) Bacteria [Presence] in Urine
256
2436
1.07
0.38
3.2
3.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
40
345
1.17
0.38
3.0
3.0
pmol/l
4.0
4.3
2.17
34
293
(3026389) Candida sp identified in Specimen by Organism specific culture
13
98
1.33
0.37
1.2
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
112
0.71
0.37
2.1
3.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
37
1.35
0.37
2.8
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
202
0.79
0.37
1.8
2.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
28
332
0.84
0.36
1.6
2.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
102
938
1.10
0.36
2.0
2.6
ug/l
4.3
6.5
1.16
85
785
(3037522) Nuclear Ab [Titer] in Serum
73
806
0.90
0.36
1.3
1.3
titre
480.0
426.0
0.21
18
188
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
71
1.27
0.36
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
55
489
1.13
0.35
3.6
3.1
e9/l
3.6
4.2
1.01
34
353
(3004616) Nuclear Ab [Presence] in Serum
5
78
0.64
0.35
2.2
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
86
940
0.91
0.35
3.0
3.3
ng/l
286.7
273.6
0.06
81
861
(44790047)
13
99
1.32
0.35
1.3
1.4
—
—
—
0
0
(44790049)
13
99
1.32
0.35
1.3
1.4
—
—
—
0
0
(44806118)
13
99
1.32
0.35
1.3
1.4
—
—
—
0
0
(44790048)
13
99
1.32
0.35
1.3
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
135
1.26
0.35
1.2
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
273
1.18
0.35
2.2
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
31
361
0.85
0.34
1.2
1.4
—
41.1
—
0
19
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
321
1.16
0.34
1.3
1.2
iu/ml
44.8
132.0
3.00
14
119
(3047189) Immunofixation for 24 hour Urine
6
45
1.34
0.33
1.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
44
498
0.88
0.33
2.6
2.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
46
1.31
0.33
1.7
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
46
1.31
0.33
1.7
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
180
1704
1.07
0.32
2.2
1.9
—
—
—
0
0
(3004451) EKG impression Narrative
6
47
1.28
0.32
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
63
694
0.90
0.31
3.1
3.7
ng/l
82.0
99.4
0.92
57
590
(3004789) Transferrin [Mass/volume] in Serum or Plasma
145
1365
1.07
0.31
2.1
2.4
g/l
2.2
2.2
1.03
130
1247
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
54
1.30
0.30
2.7
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
54
1.30
0.30
2.7
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
120
1.25
0.30
1.6
2.6
mg/l
51.0
20.2
—
5
32
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
102
1.28
0.30
1.8
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
78
717
1.09
0.30
3.5
4.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
437
4491
0.96
0.29
4.2
3.1
u/l
119.2
55.2
6.14
401
4065
(40768800) Prostate Pathology biopsy report
18
217
0.83
0.29
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
206
0.82
0.29
1.9
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
51
460
1.11
0.28
5.8
3.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
103
1.27
0.28
1.8
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
103
1.27
0.28
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
103
1.27
0.28
1.8
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
266
2561
1.05
0.28
3.2
3.5
e6/l
0.8
0.6
0.56
219
2009
(3017704) Immunofixation for Urine
8
63
1.27
0.27
1.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
64
1.25
0.27
1.1
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
65
1.23
0.27
1.8
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
65
1.23
0.27
1.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
104
1.25
0.26
1.8
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
29
331
0.87
0.26
1.1
1.3
—
4.9
—
0
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
75
0.67
0.26
1.0
1.1
—
—
—
0
0
(4306422)
5
75
0.67
0.26
1.0
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
318
0.88
0.24
3.8
2.7
g/l
0.2
0.3
1.03
14
120
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
6
82
0.73
0.24
1.2
1.2
—
230.2
—
0
26
(3021589) Normoblasts [#/volume] in Blood
329
3386
0.96
0.24
13.6
10.0
e9/l
0.0
0.0
0.15
269
2762
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
124
1.21
0.24
1.4
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
203
1951
1.05
0.23
3.2
3.0
mosm/kgh2o
534.3
560.0
1.00
182
1659
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
29
256
1.14
0.23
1.4
1.7
—
211.7
—
0
12
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(44806420)
5
39
1.28
0.23
2.4
2.4
—
—
—
0
0
(3019225) pH of Specimen
95
894
1.07
0.22
5.6
4.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
102.5
—
0
11
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
11
0.00
0.21
0.0
11.0
—
6.5
—
0
11
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
135
1288
1.05
0.21
2.2
2.5
%
19.9
21.3
0.58
117
1092
(3050794) Legionella sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
8.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
230
0.87
0.21
2.5
2.4
ug/min
145.3
85.6
0.22
14
133
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
64
596
1.08
0.20
7.4
8.2
%
0.7
0.7
0.21
64
589
(3036071) Salmonella sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
0.5
—
0
9
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
153
1470
1.05
0.19
3.0
3.2
e6/l
3.2
2.1
0.80
96
857
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
59
632
0.93
0.19
3.7
3.1
ml/min/173m2
60.5
58.2
0.21
22
288
(3030981) Hyaline casts [#/volume] in Urine by Automated count
56
521
1.08
0.19
3.6
2.9
e6/l
0.4
0.4
0.03
56
507
(3014271) Vancomycin [Susceptibility]
10
81
1.24
0.18
3.0
3.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
68
638
1.07
0.18
4.8
3.8
kpa
5.1
5.2
0.22
62
584
(3049717) Cytology report of Urine Cyto stain
41
446
0.92
0.18
2.6
3.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
34
372
0.91
0.17
5.2
3.4
mmol/l
1.5
1.5
0.05
34
365
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
66
0.76
0.17
1.4
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
67
0.75
0.17
1.0
1.1
nmol/l
1.2
1.5
—
5
55
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
5
69
0.72
0.17
1.0
1.1
%
123.0
114.9
—
5
63
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
101
1.19
0.16
1.9
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
156
1507
1.04
0.16
21.4
29.4
inr
1.5
1.5
0.11
21
189
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
83
1.21
0.15
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
51
544
0.93
0.15
1.6
2.2
nmol/l
9.8
12.1
0.95
41
462
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
22
197
1.12
0.15
1.4
1.6
iu/ml
0.1
24.6
—
7
49
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
381
1.08
0.15
2.2
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
295
0.91
0.14
1.1
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
84
1.19
0.14
1.6
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
598
1.06
0.13
5.0
3.9
mmol/l
1.4
2.0
0.69
52
445
(3000850) Epithelial cells [#/volume] in Urine
208
2029
1.03
0.13
2.8
2.7
e6/l
5.3
4.8
0.47
193
1792
(3000991) Gas panel - Venous blood
83
796
1.05
0.12
5.9
7.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
150
1543
0.97
0.12
2.6
3.0
e6/l
2.3
1.2
1.32
94
922
(3005322) IgE [Units/volume] in Serum or Plasma
32
344
0.93
0.12
1.2
1.2
u/ml
172.7
165.4
0.02
25
314
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
230
1.09
0.11
1.2
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
136
0.88
0.11
1.4
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
19
208
0.91
0.10
1.6
2.2
g/l
118.2
126.8
0.56
13
158
(40768793) Breast Pathology biopsy report
16
144
1.11
0.10
1.1
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
63
604
1.05
0.10
1.6
1.6
%
1.6
1.6
0.34
55
494
(42529406) Shigella sp [Presence] in Stool by Culture
25
232
1.08
0.10
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
207
0.92
0.09
3.4
3.9
mg/l
41.4
29.6
0.45
12
140
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
123
1198
1.03
0.09
1.9
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
145
0.90
0.09
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
28
299
0.93
0.09
2.2
3.3
nmol/l
0.7
0.9
1.04
16
237
(3024263) Appearance of Synovial fluid
5
48
1.04
0.09
1.8
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
63
655
0.96
0.09
7.4
6.0
mmol/l
24.8
24.5
0.34
63
609
(3011648) Oxygen content in Venous blood
5
64
0.78
0.08
2.8
1.5
%
9.8
11.1
—
5
64
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
82
0.85
0.07
1.7
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
119
1165
1.02
0.07
5.9
6.4
mmol/l
1.2
1.4
0.19
94
881
(21494434) Karyotype in Bone marrow
9
85
1.06
0.07
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
87
1.03
0.07
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
102
0.88
0.06
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
152
0.92
0.06
1.8
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
327
3301
0.99
0.06
3.6
3.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
158
1.08
0.06
3.8
2.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
637
6337
1.01
0.06
14.3
7.2
u/l
124.5
81.6
9.65
613
5856
(1761482) Bacteria [#/volume] in Urine by Culture
32
306
1.05
0.05
3.8
5.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
314
3167
0.99
0.05
4.1
4.0
e6/l
307.7
134.1
0.43
255
2383
(3002179) Metamyelocytes/100 leukocytes in Blood
56
575
0.97
0.04
4.9
3.8
%
0.8
0.6
0.23
18
161
(3023419) Bacteria identified in Sputum by Culture
12
130
0.92
0.04
1.7
2.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
229
1.05
0.04
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
169
1671
1.01
0.04
1.8
1.6
mg/l
2.0
1.4
1.27
128
1326
(3016502) Oxygen saturation in Arterial blood
103
1046
0.98
0.04
6.0
6.7
%
94.7
94.9
0.12
103
1000
(3044927) Protein electrophoresis panel - Urine
13
122
1.07
0.02
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
142
1.06
0.02
1.1
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
142
1.06
0.02
2.3
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
20
208
0.96
0.02
2.0
1.7
e6/l
11274.3
18235.2
0.43
15
144
(3007164) IgA [Mass/volume] in Serum or Plasma
121
1221
0.99
0.02
1.7
1.3
g/l
2.5
2.7
0.53
81
686
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
243
1.03
0.01
1.6
1.4
ug/g
225.8
275.2
0.56
17
146
(3025159) Blasts/100 leukocytes in Blood
56
567
0.99
0.01
5.4
3.8
%
0.3
0.2
0.13
25
170
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
114
0.96
0.00
1.6
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
114
0.96
0.00
1.3
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
176
1.02
0.00
1.7
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
119
1194
1.00
0.00
1.9
1.8
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
60
602
1.00
0.00
7.4
8.1
%
1.3
1.4
0.41
60
595
(3003327) Ova and parasites identified in Stool by Light microscopy
18
181
0.99
0.00
1.8
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
83
828
1.00
0.00
1.2
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
94
942
1.00
0.00
3.3
3.4
mmol/l
2.1
2.1
0.02
65
744
(3019060) Gas panel - Arterial blood
71
709
1.00
0.00
4.2
4.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
21
207
1.01
0.00
1.7
2.5
%
16.4
15.6
—
5
104
(3019832) Treponema pallidum Ab [Presence] in Serum
23
233
0.99
0.00
1.2
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
145
1.03
0.00
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
50
1.00
0.00
1.2
1.5
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
3.0
—
0.6
—
0
8
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
130
1.00
0.00
1.3
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
6
60
1.00
0.00
1.3
2.1
—
80.5
—
0
10
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
56
0.89
0.00
4.4
4.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
49
1.02
0.00
1.4
1.7
u/field
1.4
3.7
—
5
31
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
25.6
—
0
5
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
5
49
1.02
0.00
1.6
1.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
53
0.94
0.00
1.0
1.3
—
38.4
—
0
5
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
53
0.94
0.00
1.0
1.6
umol/l
13.8
16.0
—
5
48
(4146454)
9
96
0.94
0.00
2.0
2.6
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
15.8
—
130.4
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
1.6
1.7
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_SECONDARY_WITHOUT_SITESPEC – Malignant neoplasm, without specification of site

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).